Xeris Biopharma Holdings XERS reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Xeris Biopharma Holdings reported in-line EPS of $-0.25 versus an estimate of $-0.25.
Revenue was up $13.86 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.18 which was followed by a 3.05% increase in the share price the next day.
Here's a look at Xeris Biopharma Holdings's past performance:
Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
---|---|---|---|---|
EPS Estimate | -0.24 | -0.37 | -0.30 | -0.34 |
EPS Actual | -0.42 | -0.39 | -0.41 | -0.30 |
Revenue Estimate | 18.90M | 11.03M | 9.54M | 7.47M |
Revenue Actual | 21.43M | 11.04M | 8.84M | 8.05M |
To track all earnings releases for Xeris Biopharma Holdings visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.